Assembly Biosciences Inc (ASMB):企業の財務・戦略的SWOT分析

◆英語タイトル:Assembly Biosciences Inc (ASMB) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH141429FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥68,400見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥102,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Assembly Biosciences Inc (Assembly), formerly Ventrus Biosciences Inc is a biotechnology company that develops, discovers, and commercializes small molecule therapies. The company develops therapies for the treatment of infectious diseases such as microbiotic therapies for Clostridium difficile (C. difficile) infections (CDI) and chronic hepatitis B virus (HBV). It also develops Gemicel platform technology that helps for targeted oral delivery vaccines, small molecules, live biotherapeutics, and complex macromolecules that are aimed for specific region in gastrointestinal tract (GI). Assembly’s HBV Cure program target’s the chronic hepatitis B virus infection. The company owns and operates its research and development facilities located in Indiana, New York, and California, the US. Assembly is headquartered in Carmel, Indiana, the US.

Assembly Biosciences Inc Key Recent Developments

Feb 25,2021: Assembly Biosciences reports fourth quarter and year end 2020 financial results and recent highlights
Feb 19,2021: Assembly Bio Announces Upcoming Investor Events
Dec 08,2020: Assembly Biosciences to wind-down microbiome program
Nov 17,2020: Assembly Biosciences appoints Nicole S. White, PhD, as senior vice president of pharmaceutical development and manufacturing
Nov 13,2020: Assembly Biosciences presents data from HBV core inhibitor programs in poster sessions at the 2020 AASLD The Liver Meeting Digital Experience

This comprehensive SWOT profile of Assembly Biosciences Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Assembly Biosciences Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Assembly Biosciences Inc – Key Information
Assembly Biosciences Inc – Overview
Assembly Biosciences Inc – Key Employees
Assembly Biosciences Inc – Key Employee Biographies
Assembly Biosciences Inc – Key Operational Heads
Assembly Biosciences Inc – Major Products and Services
Assembly Biosciences Inc – History
Assembly Biosciences Inc – Company Statement
Assembly Biosciences Inc – Locations And Subsidiaries
Assembly Biosciences Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Assembly Biosciences Inc – Business Description
Assembly Biosciences Inc – Corporate Strategy
Assembly Biosciences Inc – SWOT Analysis
SWOT Analysis – Overview
Assembly Biosciences Inc – Strengths
Assembly Biosciences Inc – Weaknesses
Assembly Biosciences Inc – Opportunities
Assembly Biosciences Inc – Threats
Assembly Biosciences Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Assembly Biosciences Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Assembly Biosciences Inc, Key Information
Assembly Biosciences Inc, Key Ratios
Assembly Biosciences Inc, Share Data
Assembly Biosciences Inc, Major Products and Services
Assembly Biosciences Inc, History
Assembly Biosciences Inc, Key Employees
Assembly Biosciences Inc, Key Employee Biographies
Assembly Biosciences Inc, Key Operational Heads
Assembly Biosciences Inc, Other Locations
Assembly Biosciences Inc, Subsidiaries
Assembly Biosciences Inc, Key Competitors
Assembly Biosciences Inc, SWOT Analysis
Assembly Biosciences Inc, Ratios based on current share price
Assembly Biosciences Inc, Annual Ratios
Assembly Biosciences Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Assembly Biosciences Inc (ASMB):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Loral Space & Communications Inc (LORL):企業の財務・戦略的SWOT分析
    Loral Space & Communications Inc (LORL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Asahi Kasei Corporation:企業のM&A・事業提携・投資動向
    Asahi Kasei Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Asahi Kasei Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Union des Groupements d’Achats Publics:企業の戦略的SWOT分析
    Union des Groupements d'Achats Publics - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • Allied Irish Banks, Plc:企業のM&A・事業提携・投資動向
    Allied Irish Banks, Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Allied Irish Banks, Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Korea Development Bank:企業の戦略・SWOT・財務情報
    Korea Development Bank - Strategy, SWOT and Corporate Finance Report Summary Korea Development Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • EyeGate Pharmaceuticals Inc (EYEG)-医療機器分野:企業M&A・提携分析
    Summary EyeGate Pharmaceuticals Inc (EyeGate) is a clinical-stage specialty pharmaceutical company that offers eye care medicines. The company offers macular edema and non-infectious anterior uveitis. It offers technologies for most prevalent issues in ophthalmic care; the existing lack of patient a …
  • Gebr. Heinemann SE & Co KG:企業の戦略・SWOT・財務分析
    Gebr. Heinemann SE & Co KG - Strategy, SWOT and Corporate Finance Report Summary Gebr. Heinemann SE & Co KG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Alimentation Couche-Tard Inc. (ATD.B)-石油・ガス分野:企業M&A・提携分析
    Summary Alimentation Couche-Tard Inc. (Couche-Tard) is a retail company that operates an extensive network of convenience stores. The company principally offers food and non-food items as well as transportation fuels. Couche-Tard products include tobacco, alcohol, grocery items, candy, snacks and va …
  • Bassett Furniture Industries Inc (BSET):企業の財務・戦略的SWOT分析
    Bassett Furniture Industries Inc (BSET) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • TauRx Pharmaceuticals Ltd:医療機器:M&Aディール及び事業提携情報
    Summary TauRx Pharmaceuticals Ltd (TauRx) discovers, develops and commercializes treatments and diagnostics for Alzheimer's disease and other neurodegenerative diseases. Its pipeline products include LMTX, a tau aggregation inhibitor (TAI) for Alzheimer’s and Behavioural variant frontotemporal demen …
  • Kuwait Petroleum International Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Kuwait Petroleum International Ltd (KPI), a subsidiary of Kuwait Petroleum Corporation, is a downstream energy company. It carries out refining of crude oil, production and marketing of refined petroleum products. The company operates refinery in Milazzo, Italy, and has retail service statio …
  • VIA Technologies, Inc (2388):企業の財務・戦略的SWOT分析
    VIA Technologies, Inc (2388) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • International Seaways Inc (INSW)-石油・ガス分野:企業M&A・提携分析
    Summary International Seaways Inc (INSW) owns and operates a fleet of oceangoing vessels involved in the transportation of crude oil and petroleum products. The company holds ownership in LNG (liquefied natural gas) carriers and FSO (floating storage and offloading) service vessels. It charters the …
  • Tainergy Tech Co Ltd (4934):電力:M&Aディール及び事業提携情報
    Summary Tainergy Tech Co Ltd (Tainergy) is a renewable energy company that designs, develops, manufactures and markets solar energy products. The company provides products such as solar deionized water systems, multi-crystalline silicon solar cell, standard solar modules, solar module with build in …
  • BioMark Diagnostics Inc:医療機器:M&Aディール及び事業提携情報
    Summary BioMark Diagnostics Inc (BioMark Diagnostics) is an oncology-focused medical equipment company that owns and develops multiple intellectual properties in detection and quantitation of metabolites. The company’s advanced near-to- market diagnostic technologies designed to improve patient outc …
  • Gr. Sarantis S.A. (SAR):企業の財務・戦略的SWOT分析
    Gr. Sarantis S.A. (SAR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • PrIME Biologics Pte Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary PrIME Biologics Pte Ltd (PrIME Biologics) is a biotechnology company that develops and manufactures plasma products for human use. The company uses Preparative Isolation by Membrane Electrophoresis ((PrIME) technology, a disposable, fully-scalable and modular manufacturing process, to manufa …
  • Occidental Petroleum Corp (OXY):石油・ガス:M&Aディール及び事業提携情報
    Summary Occidental Petroleum Corp (Occidental) is an oil and gas exploration and production company with integrated assets. The company is active in upstream exploration and production; midstream and marketing; and chemicals business. The oil and gas business explores for, develops and produces oil, …
  • Rovsing AS:企業の戦略・SWOT・財務分析
    Rovsing AS - Strategy, SWOT and Corporate Finance Report Summary Rovsing AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Encore Dermatology Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Encore Dermatology Inc (Encore Dermatology) is a specialty dermatology company, which develops and commercializes novel prescription medicines and medical devices for the treatment of topical dermatological disorders. The company’s products include HylatopicPlus lotion, a combination of vari …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆